Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
NCT ID: NCT01318902
Term: Cardiac failure congestive
Organ System: Cardiac disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 21.0
Notes: One treatment-emergent death occurred during treatment with Dose Expansion Cohort: Ixazomib 4 mg (PI Naive) and is not related.
Study: NCT01318902
Study Brief: Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 1 6 View
EG001 None 0 5 View
EG002 None 1 5 View
EG003 None 0 11 View